Human chorionic gonadotropin therapy in hypogonadic severe-oligozoospermic men and its effect on semen parameters |
Andrabi, Syed Waseem
(Department of Zoology, University of Lucknow)
Makker, Giresh Chandra (Makker IVF Centre) Makker, Renu (Makker IVF Centre) Mishra, Geetanjali (Department of Zoology, University of Lucknow) Singh, Rajender (Division of Endocrinology, CSIR-Central Drug Research Institute) |
1 | Rohrmann S, Platz EA, Selvin E, Shiels MS, Joshu CE, Menke A, et al. The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol (Oxf) 2011;75:232-9. DOI |
2 | Andrabi SW, Saini P, Joshi M, Mehta P, Makker GC, Mishra G, et al. HCG therapy in azoospermic men with lower or borderline testosterone levels and the prognostic value of Y-deletion analysis in its outcome. Andrologia 2022;54:e14251. |
3 | Waseem AS, Singh V, Makker GC, Trivedi S, Mishra G, Singh K, et al. AZF deletions in Indian populations: original study and meta-analyses. J Assist Reprod Genet 2020;37:459-69. DOI |
4 | Kamel RM. Management of the infertile couple: an evidence-based protocol. Reprod Biol Endocrinol 2010;8:21. DOI |
5 | Lee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol 2018;7(Suppl 3):S348-52. DOI |
6 | Silva FR, Leite LD, Wassermann GF. Rapid signal transduction in Sertoli cells. Eur J Endocrinol 2002;147:425-33. DOI |
7 | Ramaswamy S, Weinbauer GF. Endocrine control of spermatogenesis: role of FSH and LH/ testosterone. Spermatogenesis 2015;4:e996025. DOI |
8 | Carnegie C. Diagnosis of hypogonadism: clinical assessments and laboratory tests. Rev Urol 2004;6 Suppl 6:S3-8. |
9 | Khera M, Broderick GA, Carson CC 3rd, Dobs AS, Faraday MM, Goldstein I, et al. Adult-onset hypogonadism. Mayo Clin Proc 2016;91:908-26. DOI |
10 | Lo EM, Rodriguez KM, Pastuszak AW, Khera M. Alternatives to testosterone therapy: a review. Sex Med Rev 2018;6:106-13. DOI |
11 | World Health Organization. WHO laboratory manual for the examination and processing of human semen. Geneva: World Health Organization; 2021. |
12 | Krausz C, Hoefsloot L, Simoni M, Tuttelmann F, European Academy of Andrology; European Molecular Genetics Quality Network. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013. Andrology 2014;2:5-19. DOI |
13 | Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab 2009;94:801-8. DOI |
14 | Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med 2013;173:1465-6. DOI |
15 | Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol 2012;2012:625434. DOI |
16 | Whitten SJ, Nangia AK, Kolettis PN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. Fertil Steril 2006;86:1664-8. DOI |